vimarsana.com

Latest Breaking News On - Roll outs - Page 6 : vimarsana.com

Transcripts for BBCNEWS The Papers 20220103 23:46:00

that, but they have been criticised for delay in that, but they have been criticised for delay in the last few months, particularly around getting the third particularly around getting the third jab, the boosterjab programme started. third jab, the boosterjab programme started, and secondly delays around announcing roll outs or devising the governments to advance roll out to children governments to advance roll out to children i governments to advance roll out to children. i do think that is something to bear in mind. yes, we have countries like israel going ahead have countries like israel going ahead with order groups with the fourth ahead with order groups with the fourthjab ahead with order groups with the fourthjab and the jc ahead with order groups with the fourth jab and the jc vi saying we need fourth jab and the jc vi saying we need more evidence older age groups need more evidence older age groups the need more evidence older age groups. the roll

Transcripts for BBCNEWS BBC News at Ten 20210804 21:10:00

questions. for example, why did the jcvi change its advice and matter of weeks, having said at the end of july that the health benefits did not outweigh the risks, they would keep it under review now there is more data, they say, reducing safety concerns and showing the spread was much more rapid amongst younger age groups, so there was more of a justification. people want to see the data, and some are saying why did the jcvi the data, and some are saying why did thejcvi not act the data, and some are saying why did the jcvi not act sooner. the data, and some are saying why did thejcvi not act sooner. then there s the issue of second doses of 16 and 17 year olds. there was no clarity about that, we were told it could be 12 weeks or more, while data is being studied, although officials did say this was not a one dose strategy. then what about 12 year olds and over? in the us, canada and france, for example, there are routine vaccinations in that age group. it was very much left on the t

Transcripts for BBCNEWS Outside Source 20211215 19:08:00

know is we are not yet sure whether it was to protect from severe disease and death. it likely is not at its highest level as he would like. the good news is it looks like boosters can restore a significant part of his protection and hopefully specifically against that hospitalisation and death. but we are still waiting to find out exactly how effective boosters are but i think the strategy of trying to get them into as many arms as possible for countries that already have the roll outs under way is probably a good option right now. next let s hearfrom paul hunter a professor of medicine here in the uk who took part in a who meeting earlier today. today s meeting was a lot of people sharing results of laboratory studies of immunity and i think the key message is that although we cannot be certain about how that will translate into the real world there is hope that their immunity holds up against omicron and there is good evidence that actually the mutations that have happened in

Transcripts for BBCNEWS BBC News 20211212 20:14:00

Transcripts for BBCNEWS BBC News 20211212 20:14:00
archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.

Transcripts for BBCNEWS BBC News 20211212 20:24:00

Transcripts for BBCNEWS BBC News 20211212 20:24:00
archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.